PF-03084014
Drug timelines are a Plus or Pro feature.
8 regulatory and trial events tracked for PF-03084014, covering 2015-07-23 to 2020-02-05. Get the full timeline:
Most recent: Clinical Trial Update: Phase II Trial of the Gamma-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors/Aggressive Fibromatosis [Phase 2]